Prednisone Anhydrous
Generic Name: prednisone anhydrous
Dosage form: POWDER. Active ingredients: PREDNISONE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Overview
Dosage form: POWDER. Active ingredients: PREDNISONE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Dosage
Available as powder.
Related Medications
Bevacizumab
bevacizumab
11 DESCRIPTION Bevacizumab-tnjn is a vascular endothelial growth factor inhibitor. Bevacizumab-tnjn is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-tnjn has an approximate molecular weight of 149 kDa. Bevacizumab-tnjn is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin Usp, Phenylephrine Hydrochloride
acetaminophen, dextromethorphan hydrobromide, guaifenesin usp, phenylephrine hydrochloride
Expectorant [EPC]
Purpose Active ingredients (in each 10mL=2 teaspoonful) Purpose Acetaminophen 500 mg Pain reliever/ fever reducer Dextromethorphan HBr 26.66 mg Cough suppressant Guaifenesin 400 mg Expectorant Phenylephrine HCl 10 mg Nasal decongestant
Daspone
daspone
Sulfone [EPC]
11 DESCRIPTION Dapsone gel, 7.5%, contains dapsone USP, a sulfone, in an aqueous gel base for topical dermatologic use. Dapsone gel, 7.5% is an off-white to yellow gel with suspended particles. Chemically, dapsone, USP has an empirical formula of C 12 H 12 N 2 O 2 S. It is a white or slightly yellow-white, crystalline powder that has a molecular weight of 248.30.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.